The Clinical Study of Urokinase-Type Plasminogen Activator and Vascular Endothelial Growth Factor in Gastric Cancer

被引：0

作者：

Xue-wen Yang

Feng Gao

Ya-jun Chen

Feng-meng Teng

机构：

[1] Jiangsu Province Hospital of TCM,Department of Laboratory Medicine

来源：

Cell Biochemistry and Biophysics | 2015年 / 72卷

关键词：

Urokinase-type; Plasminogen activator; Vascular endothelial growth factor; Gastric cancer;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The aim of this study is to explore the expression and significance of urokinase-type plasminogen activator (u-PA) and vascular endothelial growth factor (VEGF) in gastric cancer, providing a novel insight for the diagnosis and treatment of gastric cancer. The gastric cancer specimens, which were excised from 87 patients and confirmed during July, 2012–July, 2014, were selected as observation group, and the normal tissue next to the tumor (more than 5 cm from the edge of the tumor) from 45 patients were randomly selected as control. u-PA and VEGF were detected by immunohistochemistry for the analysis of the correlation of u-PA and VEGF in two groups. The positive rates of u-PA and VEGF in gastric cancer tissue were 81.61 and 79.31 %, respectively, which were 6.67 and 8.89 % in the control group, respectively. The positive rates in the observation group were obviously higher than those in the control group, and the difference was statistically significant (P < 0.05). Among the 87 gastric cancer tissue samples from the observation group, the positive rates of u-PA and VEGF in the gastric cancer with poor differentiation, lymphatic metastasis, invasion up to serosal layer, and TNM stage III + IV were obviously higher than those in the gastric cancer with high differentiation, non-lymphatic metastasis, invasion not up to the serosal layer, and TNM stage I + II, and the difference was statistically significant (P < 0.05). Among the 87 gastric cancer tissue samples from the observation group, u-PA and VEGF were found to be positive in 60 cases and negative in 7 cases. By comparing the two groups, u-PA and VEGF were positively correlated in gastric cancer tissue (P < 0.05). u-PA and VEGF were highly expressed in gastric cancer tissue, which could be used as the molecular biological indicators to predict the invasion and metastasis potential of gastric cancer. The combination of two factors plays a guiding role in early diagnosis and treatment of gastric cancer.

引用

页码：649 / 652

页数：3

共 33 条

[1]

Villanueva MT(2014)Therapeutics: Gastric cancer gets a red carpet treatment Nature Reviews Cancer 14 647-1889

[2]

Ding Y(2012)u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer World Journal of Surgical Oncology 10 270-3278

[3]

Roomi MW(2013)Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines International Journal of Oncology 42 1883-162

[4]

Weiss TW(2011)Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivo Anticancer Research 31 3273-280

[5]

Ho YT(2009)Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, u-PA and MMP-2 and -9 Cancer Letters 279 155-1563

[6]

Kigure W(2013)The association of VEGF-C expression with tumor lymphatic vessel density and lymph node metastasis in patients with gastric cancer and gastrointestinal stromal tumor Hepato Gastroenterology 60 277-3863

[7]

Miyake K(2012)The novel hypoxic cytotoxin, TX-2098 has antitumor effect in pancreatic cancer; possible mechanism through inhibiting VEGF and hypoxia inducible factor-1alpha targeted gene expression Experimental Cell Research 318 1554-95

[8]

Zhang T(2011)Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression Anticancer Research 31 3859-465

[9]

Zhang L(2012)Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells Molecular Biology Reports 39 89-1122

[10]

Salomon-Perzynska M(2014)VEGF-targeted therapy for the treatment of cervical cancer: Literature review Ginekologia Polska 85 461-1642

← 1 2 3 4 →